Analysts predict that Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating) will post earnings per share of $0.73 for the current quarter, according to Zacks Investment Research. Two analysts provided earnings estimates for Nu Skin Enterprises. The highest EPS estimate is $0.75 and the lowest is $0.71. Nu Skin Enterprises reported earnings per share of $0.91 in the same quarter last year, which would indicate a negative 19.8% year-over-year growth rate. The company is expected to release its next results after the market closes on Monday, January 1.
According to Zacks, analysts expect Nu Skin Enterprises to report annual earnings of $4.29 per share for the current year, with EPS estimates ranging from $4.22 to $4.38. For the next fiscal year, analysts expect the company to report earnings of $4.56 per share, with EPS estimates ranging from $4.54 to $4.60. Zacks Investment Research EPS averages are an average based on a survey of research analysts who track Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS – Get Rating) last released its quarterly results on Wednesday, February 16. The company reported earnings per share (EPS) of $1.11 for the quarter, beating the Zacks consensus estimate of $0.95 by $0.16. Nu Skin Enterprises achieved a net margin of 5.46% and a return on equity of 23.39%. The company posted revenue of $673.44 million in the quarter, versus a consensus estimate of $655.93 million. During the same period last year, the company achieved EPS of $1.40. The company’s revenue for the quarter decreased 10.0% year over year.
A number of equity analysts have weighed in on NUS shares. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a Friday, February 18 report. Jefferies Financial Group raised its price target on Nu Skin Enterprises shares from $61.00 to $75.00 in a Thursday, February 17 report. StockNews.com began covering Nu Skin Enterprises shares in a report on Thursday, March 31. They issued a “holding” rating on the stock. DA Davidson raised his price target on Nu Skin Enterprises stock from $47.00 to $50.00 and gave the stock a “neutral” rating in a Thursday, February 17 research report. Finally, Zacks Investment Research upgraded Nu Skin Enterprises shares from a “hold” rating to a “strong-buy” rating and set a target price of $57.00 for the company in a Tuesday research report. March 29. Four investment analysts gave the stock a hold rating, one gave the stock a buy rating and one gave the stock a high buy rating. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $61.17.
NUS stock traded at $2.17 at midday Friday, hitting $45.33. The stock recorded a trading volume of 826,850 shares, compared to an average volume of 665,307. The company has a market capitalization of $2.26 billion, a PE ratio of 15.91 and a beta of 1.25. . The company has a debt ratio of 0.29, a current ratio of 1.65 and a quick ratio of 0.89. Nu Skin Enterprises has a 12 month minimum of $39.40 and a 12 month maximum of $62.70. The company’s 50-day moving average price is $48.34 and its 200-day moving average price is $47.43.
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 9. Investors of record on Monday, February 28 received a dividend of $0.385. This represents an annualized dividend of $1.54 and a dividend yield of 3.40%. The ex-dividend date was Friday, February 25. This is an increase from Nu Skin Enterprises’ previous quarterly dividend of $0.38. Nu Skin Enterprises’ dividend payout ratio is 54.04%.
Separately, director Andrew D. Lipman sold 1,000 shares of the company in a trade on Tuesday, February 22. The shares were sold at an average price of $53.27, for a total transaction of $53,270.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available via this link. Additionally, CEO Ryan S. Napierski sold 25,000 shares of the company in a trade on Friday, February 25. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure of this sale can be found here. During the last quarter, insiders sold 29,000 shares of the company worth $1,383,890. Insiders of the company own 4.00% of the shares of the company.
Several institutional investors have recently changed their positions in the stock. TCI Wealth Advisors Inc. increased its position in Nu Skin Enterprises by 66.6% in Q4. TCI Wealth Advisors Inc. now owns 758 shares of the company valued at $38,000 after acquiring 303 additional shares in the last quarter. Covestor Ltd bought a new position in shares of Nu Skin Enterprises in Q4, valued at around $48,000. Quadrant Capital Group LLC increased its stake in Nu Skin Enterprises by 47.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company valued at $54,000 after purchasing an additional 342 shares during the period. JJJ Advisors Inc. increased its stake in Nu Skin Enterprises by 216.9% during the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company valued at $95,000 after purchasing an additional 1,280 shares during the period. Finally, Gladius Capital Management LP acquired a new position in Nu Skin Enterprises during the fourth quarter worth approximately $98,000. Institutional investors and hedge funds hold 80.57% of the company’s shares.
About Nu Skin Enterprises (Get a rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems and ageLOC LumiSpa skin cleansing and treatment devices; and ageLOC Boost, plus a range of other cosmetic and personal care products.
Get a Free Copy of Zacks’ Research Report on Nu Skin Enterprises (NUS)
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
Receive daily news and reviews for Nu Skin Enterprises – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s free daily email newsletter.